Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Purple Biotech (PPBT)

Purple Biotech Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PPBT
DateTimeSourceHeadlineSymbolCompany
06/01/202522:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
06/01/202521:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PPBTPurple Biotech Ltd
06/12/202412:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
05/12/202412:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
05/12/202412:13GlobeNewswire Inc.Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary SharesNASDAQ:PPBTPurple Biotech Ltd
04/12/202416:40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
04/12/202414:50Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PPBTPurple Biotech Ltd
03/12/202421:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
03/12/202413:23GlobeNewswire Inc.Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary SharesNASDAQ:PPBTPurple Biotech Ltd
02/12/202412:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
02/12/202412:00GlobeNewswire Inc.Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic CancerNASDAQ:PPBTPurple Biotech Ltd
15/11/202412:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
15/11/202412:00GlobeNewswire Inc.Purple Biotech Reports Third Quarter 2024 Financial ResultsNASDAQ:PPBTPurple Biotech Ltd
04/11/202412:51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
04/11/202412:50GlobeNewswire Inc.Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of DeathNASDAQ:PPBTPurple Biotech Ltd
25/10/202411:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
25/10/202411:20GlobeNewswire Inc.Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsNASDAQ:PPBTPurple Biotech Ltd
10/10/202411:40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
10/10/202411:30GlobeNewswire Inc.Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsNASDAQ:PPBTPurple Biotech Ltd
09/10/202411:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
02/10/202420:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
18/09/202410:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
18/09/202410:30GlobeNewswire Inc.Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24NASDAQ:PPBTPurple Biotech Ltd
11/09/202420:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
10/09/202411:00GlobeNewswire Inc.Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer ResearchNASDAQ:PPBTPurple Biotech Ltd
30/08/202411:00GlobeNewswire Inc.Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:PPBTPurple Biotech Ltd
19/08/202420:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
16/08/202412:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
16/08/202412:12GlobeNewswire Inc.Purple Biotech Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:PPBTPurple Biotech Ltd
08/08/202420:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
 Showing the most relevant articles for your search:NASDAQ:PPBT